PT 141 (Bremelanotide)
Typical Dosing Protocols (Research/Compounded Use Only) – PT-141 (Bremelanotide)
Common protocol: 0.5–2 mg subcutaneously as needed, injected 45–90 minutes before sexual activity. Most users start with 0.5–1 mg and titrate based on individual response.
Other reported ranges:
Standard: 1–2 mg per dose
Lower: 0.5 mg per dose (for beginners or sensitivity)
Frequency: Maximum 2–3 times per week to avoid desensitization.
Effects typically last 24–36 hours.
Reconstitution example (for a typical 10 mg vial): Add 2 mL bacteriostatic water (yielding ~5 mg/mL).
1 mg = 0.2 mL (20 units on U-100 insulin syringe)
2 mg = 0.4 mL (40 units)
Administration: Subcutaneous injection (abdomen or thigh).
Dosing is highly individualized based on goals (libido, arousal, sexual dysfunction) and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.
){kind=link}